MedTrace Logo

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis

NCT03009136 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2017-03-14

No results posted yet for this study

Summary

The aim of this study is to investigate the short and long term efficacy and the safety of SCRT treatment for PAR

Conditions

  • Perennial Allergic Rhinitis

Interventions

DRUG

SCRT

composed of eight herbs: Glycyrrhiza uralensis Fischer 1g Zingiber officinale Roscoe 0.5g Cinnamomum cassia Blume 0.2g, Ephedra sinica Stapf 0.5g, Pinellia ternata Breitenbach 2.67g, Paeonia lactiflora PALL 1g, Asiasarum sieboldi F. Maekawa 0.5g, Schisandra chinensis 2.67g (per 9g of granules)

DRUG

Placebos

is made of lactose, corn starch and caramel coloring, and has appearance, shape, weight, taste, and color similar to SCRT

Sponsors & Collaborators

  • Kyung Hee University Hospital

    collaborator OTHER

  • Pusan National University Hospital

    collaborator OTHER

  • Semyung University Affiliated Oriental Medical Hospital

    collaborator OTHER

  • DongGuk University

    collaborator OTHER

  • Kyung Hee University Hospital at Gangdong

    lead OTHER

Principal Investigators

  • Minhee Kim · Kyung Hee University Hospital at Gangdong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03009136 on ClinicalTrials.gov